Postbiotics as a therapeutic tool in Alzheimer's disease: Insights into molecular pathways and neuroprotective effects
Authors:
- Khadga Raj AranKAKhadga Raj Aran
- RohitRORohit
- 6 February 2025
- journal article
- review article
- Published by Elsevier in Ageing Research Reviews
- Vol. 106, 102685
Abstract
No abstract availableKeywords
This publication has 134 references indexed in Scilit:
- Modulation of gut‐microbiota through probiotics and dietary interventions to improve host healthJournal of the Science of Food and Agriculture, 2024
- From probiotics to postbiotics: Concepts and applicationsAnimal Research and One Health, 2023
- Role of the Gut Microbiome and Its Modulation in Neurodegenerative Diseases2022
- Glia: A major player in glutamate–GABA dysregulation‐mediated neurodegenerationJournal of Neuroscience Research, 2021
- Oxidativestress‐Adirect bridge to central nervous system homeostatic dysfunction and Alzheimer's diseaseCell Biochemistry and Function, 2021
- GABAergic signaling by cells of the immune system: more the rule than the exceptionCellular and Molecular Life Sciences, 2021
- Pharmacology of Dopamine and Its Receptors2020
- Clearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytesCellular and Molecular Life Sciences, 2017
- Microtubule Organization and Microtubule-Associated Proteins (MAPs)2016
- Astrocytes are GABAergic cells that modulate microglial activityGlia, 2010